ClearPoint Neuro amends At-the-Market sales agreement
ClearPoint Neuro amended an existing equity deal with Stifel Nicolaus to extend the maximum offering size by $150 million. The amendment confirms the effective date of the original agreement to November 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed